Close
Nordic 9Nordic 9

Northumbria University (investor - Corporate Investor)

United Kingdom
See something wrong or missing? Let us know
Offices:Newcastle
Average round investment:889.7k USD
Average number per year:1.0
Distribution: 2024 (1)
Portfolio companies: United Kingdom PulmoBiomed
Mostly invests in: United Kingdom United Kingdom (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Northumbria University

Name Criteria
United Kingdom Mike Watson
83%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom GM&C Life Science Fund
83%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland Nostetta Ventures
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Linnéa Capital
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Sweden Håkan Svanberg
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Denmark Blazar Capital
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Healthy.Capital
78%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Italy StartupGym
78%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
Sweden Mattias Weinhandl
78%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
Switzerland Venture Kick
78%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
Top